Veritex insider cashes out $1.6M via option exercise & sale
Rhea-AI Filing Summary
Veritex Holdings (VBTX) – Form 4 filed 07/24/25
EVP & Credit Risk Officer Angela Harper executed a same-day option exercise-and-sale program on 07/23/25. She exercised 47,716 options from five grants (strike $21.38-$29.13) and sold the resulting shares in the open market at weighted-average prices near $32.36-$32.38. Gross spread per share was roughly $3-$11, producing estimated pre-tax proceeds of about $1.6 million.
Because each sale matched the corresponding exercise, Harper’s direct common-stock holding finished unchanged at 59,683 shares. The option positions reported in Table II are now fully exhausted, leaving no derivative balance tied to the exercised grants. No other equity awards or indirect holdings were disclosed.
The transaction is best characterized as monetization rather than accumulation; it neither increases nor decreases the insider’s core share ownership but removes upside leverage previously embedded in the option awards.
Positive
- None.
Negative
- Significant insider sale: Officer sold 47,716 shares worth ≈$1.5 m, which can be interpreted as a modestly bearish sentiment signal.
Insights
TL;DR: Insider monetizes 47.7k options, no change in share count—optically negative but economically neutral.
The filing shows a classic exercise-and-sell: five tranches of in-the-money employee stock options were converted and immediately liquidated. While the sale volume (≈$1.54 m at avg $32.37) may trigger headline "insider selling" screens, the officer retains the same 59,683 shares she held pre-trade. Thus, her long-equity exposure is intact; only option leverage is gone. From a market-signal perspective, cashing out the upside could be viewed as modestly bearish because management elected liquidity over holding discounted shares. The move is not tied to earnings or strategic events, so overall impact on valuation is limited.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 3,675 | $26.71 | $98K |
| Exercise | Employee Stock Option (right to buy) | 4,727 | $27.59 | $130K |
| Exercise | Employee Stock Option (right to buy) | 7,902 | $21.38 | $169K |
| Exercise | Employee Stock Option (right to buy) | 20,000 | $21.38 | $428K |
| Exercise | Employee Stock Option (right to buy) | 11,412 | $29.13 | $332K |
| Exercise | Common Stock | 3,675 | $26.71 | $98K |
| Sale | Common Stock | 3,675 | $32.3795 | $119K |
| Exercise | Common Stock | 4,727 | $27.59 | $130K |
| Sale | Common Stock | 4,727 | $32.3556 | $153K |
| Exercise | Common Stock | 7,902 | $21.38 | $169K |
| Sale | Common Stock | 7,902 | $32.3704 | $256K |
| Exercise | Common Stock | 20,000 | $21.38 | $428K |
| Sale | Common Stock | 20,000 | $32.3649 | $647K |
| Exercise | Common Stock | 11,412 | $29.13 | $332K |
| Sale | Common Stock | 11,412 | $32.38 | $370K |
Footnotes (1)
- Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.3701 to $32.375, inclusive. Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.35 to $32.391, inclusive. Reflects the weighted average sales price for the reported transactions. The shares were sold in multiple transactions at prices ranging from $32.38 to $32.39, inclusive. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. Grant vest on January 1, 2019.
